Elanco (NYSE: ELAN) chief accounting officer uses 1,389 shares for tax withholding

Rhea-AI Filing Summary

Elanco Animal Health Inc chief accounting officer James M. Meer reported a tax-related share disposition. On the reported date, he transferred 1,389 shares of Common Stock at $24.88 per share to cover tax withholding obligations, a non-open-market transaction. After this, he directly held 66,732 Common Stock shares.

Insider Trade Summary

Net Seller: 1,389 shares

Net Sell 1 txn

Insider Meer James M

Role CHIEF ACCOUNTING OFFICER

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,389	$24.88	$35K

Holdings After Transaction: Common Stock — 66,732 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/05/2026 - 04:09 PM Learn about SEC filing dates

FAQ

What insider transaction did Elanco (ELAN) officer James M. Meer report?

James M. Meer reported a disposition of 1,389 shares of Elanco Common Stock. The transaction used shares to satisfy tax withholding obligations, rather than an open-market sale, and was coded as a tax-related payment under transaction code “F.”

How many Elanco (ELAN) shares did James M. Meer use for tax withholding?

He used 1,389 Elanco Common Stock shares for tax withholding. These shares were transferred at a reported price of $24.88 per share to cover tax liabilities associated with an equity-related event, rather than being sold on the open market.

What was the reported share price in James M. Meer’s Elanco (ELAN) Form 4?

The Form 4 reports a transaction price of $24.88 per Elanco Common Stock share. This price applies specifically to the 1,389 shares used to satisfy tax withholding obligations in a non-derivative, tax-related disposition transaction coded as “F.”

How many Elanco (ELAN) shares does James M. Meer hold after this transaction?

Following the tax-withholding disposition, James M. Meer directly holds 66,732 Elanco Common Stock shares. This figure reflects his direct ownership after transferring 1,389 shares to meet tax obligations related to an equity compensation event.

Was James M. Meer’s Elanco (ELAN) transaction an open-market sale?

The transaction was not an open-market sale; it was a tax-withholding disposition. Shares were delivered to satisfy tax liabilities, as indicated by transaction code “F” and the description referencing payment of exercise price or tax liability using securities.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Meer James M

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS IN 46221

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF ACCOUNTING OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		F		1,389	D	$24.88	66,732	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Amy C. Seidel, Attorney-in-Fact for James M. Meer	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.